Two hundred CHD equivalent ( CHD-RP@ ) , ILHDL-C cases were randomly assigned for treatment either with atorvastatin @ mg/day ( n = @ ) , micronized fenofibrate @ mg/day ( n = @ ) or niacin-extended release ( ER ) @ mg/day ( n = @ ) .